Welcome

Every product is a series of choices

Choose wisely

Johnson & Johnson · Tremfya market launch

We didn’t need the whole market. We needed the part of it most likely to move.

For the Tremfya launch, I used market and commercial data to find where focused effort had the best shot at early traction.

Real-world workProduct analyticsNational launch support

Some models here are illustrative or reconstructed. Reported outcomes are labeled separately from my analysis.

At a glance

Problem

Tremfya was entering a crowded category at a higher price. Broad coverage would’ve been expensive and inefficient.

My role

I analyzed market data, built the prioritization model, gathered regional input, and turned it into a recommendation stakeholders could act on.

Key decision

Focus first on high-volume, high-frequency opportunities with stronger expected conversion.

Business value

A clearer way for the launch team to decide where to focus, what to measure, and when to expand.
01The recommendation

Start focused. Learn quickly. Expand what works.

Don’t treat every market the same. Start where volume, prescribing frequency, and expected conversion line up. Measure what happens, then expand if the results hold up.

  1. 01

    Find the strongest opportunities

  2. 02

    Focus resources

  3. 03

    Measure conversion

  4. 04

    Expand successful routes

02Visual work

What the team could actually use

The analysis only mattered if someone could act on it. I turned the model into opportunity maps, priority segments, funnel views, and forecast scenarios so stakeholders could see where the recommendation came from.

03My role

I analyzed

Market, territory, volume, frequency, conversion, and competitive data.

I built

The prioritization model, conversion funnel, forecast scenarios, and stakeholder visuals.

I influenced

Where the team focused first, where coverage got pulled back, and how the launch could expand once it learned more.

I supported the analytics and recommendation. I didn’t make the national commercial decisions on my own.

04Decision logic

The model narrowed the market to the opportunities worth testing first

These reconstructed views show the logic, not Johnson & Johnson’s actual numbers.

  1. Total market

    No allocation decision yet — sizing only.

  2. Targetable market

    Exclude accounts we cannot reach or serve.

  3. High-volume segments

    Concentrate where prescribing volume exists.

  4. High-frequency opportunities

    Favour repeat prescribing over one-offs.

  5. High-confidence targets

    Rank by opportunity score; fund the top band.

  6. Expected conversion

    Apply historical conversion by segment.

  7. Expected volume

    Translate conversion into expected demand.

  8. Market share

    Compare against the coverage-first alternative.

Each filter was a resource-allocation decision.

Illustrative / reconstructed analytical framework — not Johnson & Johnson internal data.
PRIORITY OPPORTUNITIESLOW PRIORITY
VOLUME →CONVERSION →
Illustrative / reconstructed analytical framework — not Johnson & Johnson internal data.
Broad coverageFocused modelIllustrative / reconstructed analytical framework — not Johnson & Johnson internal data.

Expected volume index by scenario

Low case

28% expected conversion

Targeted accounts
~1,200
Expected volume
34 (index)
Expected share direction
Low single-digit early share

Base case

35% expected conversion

Targeted accounts
~1,600
Expected volume
56 (index)
Expected share direction
Mid single-digit early share

Upside case

40% expected conversion

Targeted accounts
~1,900
Expected volume
76 (index)
Expected share direction
High single-digit early share
Illustrative scenario model. Exact internal forecast data isn’t public.
05Reported results

The results were strong. They weren’t mine alone.

The broader launch reached more than 30% market share within six months, and around 85% longer term. My analysis was one part of a much larger national effort, so these are reported project outcomes, not a claim of individual credit.

>30%

Reported project outcome

Market share within six months

~85%

Reported project outcome

Market share, longer term

06Optional depth

Read the full analysis

The recommendation came first. This is the work behind it.

Discovery and regional input
  1. Sales leadership
  2. Regional teams
  3. Territory data
  4. Commercial assumptions
  5. National launch model

We gathered input from sales leaders and regional teams across the U.S. I wanted the model grounded in territory-level reality, not a single national average.

  • Prescribing patterns
  • Competitive intensity
  • Territory opportunity
  • Existing commercial routes
  • Expected conversion
  • Volume potential
Market segmentation

Broad coverage

More accounts, more spend, including lower-confidence bets.

Focused entry

Prioritize volume, frequency, and expected conversion. Prove it, then expand it.

Opportunity scoring

Inputs

  • Market volume
  • Prescription frequency
  • Historical conversion
  • Competitive intensity
  • Regional opportunity
  • Commercial coverage
  • Account / territory characteristics

Prioritization model

I combined volume, frequency, historical conversion, competitive intensity, and strategic fit so territories could be compared consistently.

Reconstructed framework

Outputs

  • Priority targets
  • Expected conversion
  • Expected volume
  • Resource requirement
  • Forecast market impact
Funnel design

Each stage cut weaker opportunities and made the allocation call explicit. The goal wasn’t a prettier funnel. It was a smaller, more useful starting set.

  1. Total market

    No allocation decision yet — sizing only.

  2. Targetable market

    Exclude accounts we cannot reach or serve.

  3. High-volume segments

    Concentrate where prescribing volume exists.

  4. High-frequency opportunities

    Favour repeat prescribing over one-offs.

  5. High-confidence targets

    Rank by opportunity score; fund the top band.

  6. Expected conversion

    Apply historical conversion by segment.

  7. Expected volume

    Translate conversion into expected demand.

  8. Market share

    Compare against the coverage-first alternative.

Each filter was a resource-allocation decision.

Illustrative / reconstructed analytical framework — not Johnson & Johnson internal data.
Forecast scenarios

I used low, base, and upside scenarios to connect target count, expected conversion, and volume. Exact internal forecast data isn’t shown.

Expected volume index by scenario

Low case

28% expected conversion

Targeted accounts
~1,200
Expected volume
34 (index)
Expected share direction
Low single-digit early share

Base case

35% expected conversion

Targeted accounts
~1,600
Expected volume
56 (index)
Expected share direction
Mid single-digit early share

Upside case

40% expected conversion

Targeted accounts
~1,900
Expected volume
76 (index)
Expected share direction
High single-digit early share
Illustrative scenario model. Exact internal forecast data isn’t public.
Resource tradeoffs

Traditional route model

25%

Illustrative conversion

  • High number of targets
  • Lower confidence per target
  • Higher resource requirement

Focused route model

35–40%

Illustrative conversion

  • Fewer initial targets
  • Higher expected confidence
  • Higher expected volume per commercial resource

These aren’t measured J&J conversion rates. They show the tradeoff between broad coverage and a more focused starting point.

Broad coverageFocused modelIllustrative / reconstructed analytical framework — not Johnson & Johnson internal data.
Stakeholder alignment
  1. Data
  2. Model
  3. Visuals
  4. Discussion
  5. Decision

I turned the analysis into a story regional and national stakeholders could respond to. Their questions helped pressure-test the assumptions before the recommendation moved forward.

What I learned
01

Start with the decision, not the dashboard.

02

Make tradeoffs visible so stakeholders can challenge them.

03

Treat early results as evidence for what to expand next.

07What I took away
01

Segment before you scale. Not every opportunity deserves the same investment.

02

Analytics should change a decision. If the allocation stays the same, the analysis didn’t do enough.

03

Clear communication is part of the product. A model only matters if people know what to do with it.